This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
A concise comparison answering Which Performs Better Index Fund Or Target Date Fund, focusing on performance, risk, and long-term suitability.
25,681 articlesA hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Public chatter around Kyle Cooke’s Salley Carson can reach beyond headlines and affect wallets. This guide breaks dow...
Public scandals can upend not just reputations but budgets. This article pulls financial lessons from the high-profil...
A short clip of a man in Brampton clearing snow with a lawnmower exploded into a national conversation about who belo...
The billionaire bill gates' foundation recently remade its public equity lineup, selling its Microsoft stake and conc...
Institutional moves can reshape a niche tech stock overnight. This article breaks down the recent liquidation by Loun...
A legendary rock family grows again, and with that milestone comes practical money lessons. This article uses the mom...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Redwire stock swung sharply during today’s session, leaving investors with questions about its business model and gro...
A growing number of American retirees are considering living on Social Security in a tropical Caribbean paradise. Thi...
Cathie Wood's Ark Invest has been quietly loading up on Nvidia this week. Here are three solid reasons why her buying...